Key result
Obesity links to ~2.6-fold higher odds of developing diabetes, driving cardiometabolic disease progression.
Why the study?
Longitudinal and bidirectional associations between obesity and cardiometabolic diseases in Chinese adults were not well characterized using network analysis.
Does obesity drive the development and clustering of cardiometabolic multimorbidity in Chinese adults?
Cohort (n=43,096)
Yes
Does obesity drive the development and clustering of cardiometabolic multimorbidity in Chinese adults?
Answers are grounded in this paper and cite their sources.
Obesity plays a central longitudinal role in driving the development and clustering of cardiometabolic multimorbidity, particularly diabetes and hypertension.
AIMS: To explore longitudinal and bidirectional associations between obesity and cardiometabolic diseases (CMDs) using a cross-lagged panel network (CLPN) framework in three nationally representative Chinese cohorts. MATERIALS AND METHODS: We analysed participants aged 45 years and older from CHARLS (2011-2015; n = 12 491), CHNS (2004-2015; n = 8412) and CFPS (2010-2022; n = 22 193). A CLPN model was used to estimate bidirectional longitudinal associations between obesity and CMDs between participant-specific first and last eligible surveys. CMDs included hypertension (HBP), diabetes (DM), ischaemic heart disease (IHD) and cerebrovascular disease (CVD). Network replicability was assessed across cohorts. RESULTS: Across cohorts, 3.43%-5.49% of participants transitioned from non-obese to obese status, while 16.44%-26.03% transitioned from no CMD to CMD status. Three networks showed moderate structural similarity, with 12 directionally concordant obesity-CMD edges and moderate edge-weight correlations (r = 0.59-0.64; all p < 0.01). The obesity-to-diabetes edge was the strongest directed association in CHARLS (OR 2.59, 95% CI:2.18-3.11) and CFPS (2.77, 2.31-3.29), and the second strongest in CHNS (3.43, 2.67-4.31). Among obesity-originating edges, the same rank order (diabetes, hypertension, IHD and CVD) was observed across cohorts. Obesity showed the highest out-expected influence and the lowest in-expected influence. A positive hypertension-to-obesity association and bidirectional hypertension-diabetes associations were consistently observed. CONCLUSIONS: CMDs are highly interrelated, and obesity plays a central role in bridging CMDs in the longitudinal networks, highlighting its relevance to both individual CMDs and their clustering as cardiometabolic multimorbidity.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2026) conducted a cohort in Cardiometabolic Multimorbidity (n=43,096). Obesity vs. Non-obese status was evaluated on Development of diabetes (obesity-to-diabetes directed association in CHARLS cohort) (OR 2.59, 95% CI 2.18-3.11, p=<0.01). Obesity played a central role in bridging cardiometabolic diseases across three cohorts, with the strongest directed association being the obesity-to-diabetes edge (OR 2.59; 95% CI 2.18-3.11).
Synapse has enriched 10 related papers. Consider them for comparative context: